Cerebain Biotech, established in 2007 and based in Costa Mesa, California, is a biomedical company specializing in the development of treatments for Alzheimer's disease. Its primary focus is the creation and clinical development of a minimally invasive, implantable medical device that leverages the regenerative properties of the omentum, a layer of tissue that generates biological agents nourishing nerves and promoting growth. Additionally, Cerebain Biotech explores synthetic drug solutions to complement its medical device offerings.
The Diabetes Reversal Group's goal is to help people with metabolic imbalances by offering a drug-free, all-natural approach to treating diabetes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.